15th April 2020 Content supplied by: BioData, Inc.
Free Access to Labguru Electronic Laboratory Notebook for COVID-19 Treatment and Vaccine Developers
BioData is offering a pro-bono programme allowing free access to its flagship Labguru electronic laboratory notebook (ELN) to academic laboratories, non-profit organizations and small start-ups working on COVID-19 treatment or vaccine development, up to a total value of $1M.
The offer comes hot on the heels of the LabRoom video conferencing service introduced free of charge to all customers last week and includes the BioData team’s commitment to rapid set up and support, as well as free access to the Labguru Academy library.
With its out-of-the-box easy setup, Labguru ELN allows more efficient lab operations and improved research output. It streamlines the planning and documenting of experiments, tracking progress, simplifying lab logistics, and sharing results.
Labguru was designed from the outset to be deployed across an entire organization within days, with seamless migration from other systems, a straightforward training program and direct access to our support function. The platform has earned its reputation and is already used by more than 80,000 researchers worldwide to accelerate laboratory output, improve inventory management and support remote collaboration.
Lab work planning and resource management are made simple through an integrated automated laboratory inventory management system and remote sample management, as well as the ability to connect the ELN with the equipment management system.
Labguru is compliant with FDA 21 CFR Part 11 regulations and provides a full audit trail.
Date Published: 15th April 2020
Source article link: View
Mobidiag Receive EUA in Finland
HALIX Provides Large-Scale GMP Facilities